Cancer Family
Digestive System Neoplasm
CI-CAN-00000012Explore in graph →
Non-malignant4,732 active trials43 approved drugs557 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000012Explore in graph →
Clinical trials
22,051 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07503847 | Shared Decision-Making for Colorectal Cancer Screening in High-Risk First-Degree Relatives Aged 40-49 | enrolling by invitation | N/A | 2,286 | National Taiwan University HospitalOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT06474091 | Liquid Biopsy MonitORing Of CholangioCarcinOma for Treatment Response and Prognostic Outcomes (MOROCCO) | enrolling by invitation | — | 100 | Mayo ClinicOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT07470658 | Optimal Surveillance Strategy After Positive FIT and Negative Colonoscopy | enrolling by invitation | — | 1,274 | National Taiwan University HospitalOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT00587314 | The Effect of Ablation Therapy on Barrett's Esophagus(ablation IN BE) | enrolling by invitation | — | 600 | Mayo ClinicOTHER | 1 | Mar 11, 2026 | clinicaltrials |
| NCT06191185 | IMProving Adherence to Colonoscopy Through Teams and Technology(IMPACTT) | enrolling by invitation | N/A | 2,000 | University of California, San FranciscoOTHER | 1 | Mar 11, 2026 | clinicaltrials |
| NCT07444099 | Early Postoperative Intervention in Gastric Cancer Patients | enrolling by invitation | N/A | 264 | Qilu Hospital of Shandong UniversityOTHER | 1 | Mar 2, 2026 | clinicaltrials |
| NCT06624189 | Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis | enrolling by invitation | — | 1,300 | NYU Langone HealthOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT07405099 | Operative Risk After Pancreatic Surgery in Patients With End Stage Renal Disease | enrolling by invitation | — | 100 | National Taiwan University HospitalOTHER | 0 | Feb 27, 2026 | clinicaltrials |
| NCT05441475 | A Phase 2, Open-Label Study of ABSK-011 Combined Atezolizumab or SOC in HCC Patients | enrolling by invitation | Phase 2 | 118 | Abbisko Therapeutics Co, LtdINDUSTRY | 1 | Feb 25, 2026 | clinicaltrials |
| NCT07429760 | Mechanical Bowel Preparation With or Without Oral Antibiotics in Left Sided Colorectal Cancer Surgery | enrolling by invitation | N/A | 60 | Shaukat Khanum Memorial Cancer Hospital & Research CentreOTHER | 1 | Feb 24, 2026 | clinicaltrials |
| NCT04693754 | Endoscopic Ultrasound Radiofrequency Ablation, Database Repository(EUS-RFA) | enrolling by invitation | — | 100 | Indiana UniversityOTHER | 1 | Feb 18, 2026 | clinicaltrials |
| NCT07395505 | Postoperative Results and Outcomes in Surgical Pelvic Exenteration(PROS-PE) | enrolling by invitation | — | 24 | Chang Gung Memorial HospitalOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT06061328 | Project OASIS: Optimizing Approaches to Select Implementation Strategies(OASIS) | enrolling by invitation | N/A | 8,020 | VA Office of Research and DevelopmentFED | 1 | Feb 4, 2026 | clinicaltrials |
| NCT07380867 | Confirming the Accuracy of Endoscopic Marking Using a New Marker, a Novel Luminomarker, in Lesion Marking Before Colorectal Cancer Surgery.(Tattooing) | enrolling by invitation | N/A | 30 | Seoul St. Mary's HospitalOTHER | 1 | Feb 2, 2026 | clinicaltrials |
| NCT07376980 | The SMART Trial: Modified Single-Stapled Anastomosis in Laparoscopic or Robotic Low Anterior Resection for Rectal Cancer(MST) | enrolling by invitation | N/A | 450 | Korea University Anam HospitalOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT02081755 | Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer | enrolling by invitation | Phase 4 | 336 | Baylor Research InstituteOTHER | 1 | Jan 27, 2026 | clinicaltrials |
| NCT07371247 | Based on ctDNA-MRD Guided Adjuvant Treatment Escalation After Definitive Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Study on Safety and Efficacy | enrolling by invitation | Early Phase 1 | 65 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Jan 27, 2026 | clinicaltrials |
| NCT07362706 | Prolonged Extubation in Gastric Cancer With OSA(Gastric Cancer) | enrolling by invitation | — | 240 | Qilu Hospital of Shandong UniversityOTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT07356466 | Clinical Efficacy of Pucotenlimab Combined With Lenvatinib and SOX Versus SOX Alone in Patients With HER2-Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma(FUGES032) | enrolling by invitation | Early Phase 1 | 100 | Fujian Medical UniversityOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT07346534 | Reinforced Versus Conventional Anastomosis in Laparoscopic Low Rectal Cancer Resection: A Comparative Study | enrolling by invitation | N/A | 300 | Shanghai 10th People's HospitalOTHER | 1 | Jan 16, 2026 | clinicaltrials |
| NCT07347158 | Effectiveness of Health Education as a Nursing Intervention in Improving Quality of Life and Reducing Symptoms of Anxiety and Depression in Ostomy Patients Following Digestive Surgery: A Quasi-Experimental Study. | enrolling by invitation | N/A | 70 | Hospital Clinico Universitario de SantiagoOTHER | 1 | Jan 16, 2026 | clinicaltrials |
| NCT07334587 | Comparison of Efficacy and Safety Between FOLFOX-6 and CAPOX in Metastatic Colorectal Carcinoma | enrolling by invitation | N/A | 248 | Allama Iqbal Medical CollegeOTHER | 1 | Jan 12, 2026 | clinicaltrials |
| NCT07312578 | Nimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy（nCT） in the Treatment of Esophageal Squamous Cell Carcinoma | enrolling by invitation | Phase 2 | 48 | Peking UniversityOTHER | 1 | Dec 31, 2025 | clinicaltrials |
| NCT06462521 | Cold Snare Piecemeal Resection vs Cold Snare Endoscopic Mucosal Resection(CARDINAL) | enrolling by invitation | N/A | 570 | Indiana UniversityOTHER | 1 | Dec 30, 2025 | clinicaltrials |
| NCT07310069 | Gemcitabine and Nab-Paclitaxel Combined With Iparomlimab and Tuvorilimab for Advanced Gallbladder Cancer(TRANSFORM-GBC) | enrolling by invitation | Phase 2 | 44 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Dec 30, 2025 | clinicaltrials |
| NCT07050485 | Postbiotics for Mitigation of Postoperative Dysbiosis in Gastrointestinal Cancer Surgery | enrolling by invitation | N/A | 30 | University of South FloridaOTHER | 1 | Dec 29, 2025 | clinicaltrials |
| NCT03793335 | Individually Tailored Strategies for the Precision Prevention of Gastric Cancer and Colorectal Cancer in the Community | enrolling by invitation | — | 40,000 | National Taiwan University HospitalOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT07290764 | Survival Analysis of Surgical Resection Versus Observation in Patients With Initially uHCC Achieving CR After Systemic Therapy | enrolling by invitation | — | 729 | Fujian Provincial HospitalOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT07289568 | Surgical Outcomes in Splenic Flexure Cancers: A Multicenter Comparison of Segmental vs. Extended Hemicolectomy (SPARROW Study)(SPARROW) | enrolling by invitation | — | 140 | Acibadem UniversityOTHER | 1 | Dec 17, 2025 | clinicaltrials |
| NCT06269744 | Proactive Outreach With FIT(PROOF) | enrolling by invitation | N/A | 3,000 | NYU Langone HealthOTHER | 1 | Dec 2, 2025 | clinicaltrials |
| NCT07241676 | Early Recurrence After Surgery for Pancreatic Cancer(POCEMON BLUE) | enrolling by invitation | — | 500 | Azienda Ospedaliera di PadovaOTHER | 1 | Nov 21, 2025 | clinicaltrials |
| NCT07230795 | AI-informed Colorectal Cancer (CRC) Screening Navigation vs. Standard of Care Among Screening-naive Penn Medicine Patients 45-49 Years Old to Increase CRC Screening Uptake | enrolling by invitation | N/A | 7,120 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Nov 17, 2025 | clinicaltrials |
| NCT04539717 | FAST (Focused Abbreviated Screening Technique)-MRI Study | enrolling by invitation | — | 820 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Oct 8, 2025 | clinicaltrials |
| NCT07121478 | Patients With High-grade Pancreatic Neuroendocrine Tumors | enrolling by invitation | Phase 2 | 46 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 1, 2025 | clinicaltrials |
| NCT07176455 | Temporal Transformation Mechanism and Intervention Strategies of Frail-related Dietary Behaviors in Older Gastric Cancer Survivors | enrolling by invitation | — | 438 | Nanjing Medical UniversityOTHER | 1 | Sep 22, 2025 | clinicaltrials |
| NCT06882876 | JS014 Combined With Toripalimab and TACE in Unresectable HCC: a Phase Ib Study | enrolling by invitation | Phase 1 | 20 | Xiangya Hospital of Central South UniversityOTHER | 1 | Sep 19, 2025 | clinicaltrials |
| NCT07171515 | Development & Clinical Application of K-PaC Registry Version 2.0 | enrolling by invitation | — | 6,923 | National Cancer Center, KoreaOTHER_GOV | 1 | Sep 12, 2025 | clinicaltrials |
| NCT06931860 | Head to Head Trial of Mailed Cologuard to Mailed FIT | enrolling by invitation | N/A | 400 | University of California, San DiegoOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT07155616 | NON-INVASIVE BLOOD FLOW ASSESSMENT: Computational Tool for Measuring Arterial Flow From CT(NOVELLA) | enrolling by invitation | — | 100 | Hospital Clinic of BarcelonaOTHER | 1 | Sep 4, 2025 | clinicaltrials |
| NCT05385861 | Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NET | enrolling by invitation | Phase 1 / Phase 2 | 52 | National Health Research Institutes, TaiwanOTHER | 1 | Aug 15, 2025 | clinicaltrials |
| NCT07107815 | A Study On The Prediction of Neoadjuvant Efficacy For Rectal Cancer Based On MR Cytometry Imaging and Deep-radiomics | enrolling by invitation | — | 250 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Aug 6, 2025 | clinicaltrials |
| NCT06391749 | Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)(K-ACCELERATE) | enrolling by invitation | — | 1,000 | Gene SolutionsINDUSTRY | 1 | Jul 16, 2025 | clinicaltrials |
| NCT07052448 | The Efficacy of Sequential RT After Triple Therapy for uHCC | enrolling by invitation | — | 35 | Fujian Provincial HospitalOTHER | 1 | Jul 4, 2025 | clinicaltrials |
| NCT07046832 | Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue Biopsy | enrolling by invitation | N/A | 104 | MediView XR, Inc.INDUSTRY | 1 | Jul 2, 2025 | clinicaltrials |
| NCT07047937 | Explainable Machine Learning for Predicting Early Gastric Cancer | enrolling by invitation | — | 10 | Wenzhou Central HospitalOTHER | 1 | Jul 2, 2025 | clinicaltrials |
| NCT07042841 | AI-Driven Quantitative Decision and Surgical Planning System for Liver Cancer | enrolling by invitation | — | 300 | Beijing Tsinghua Chang Gung HospitalOTHER | 1 | Jun 29, 2025 | clinicaltrials |
| NCT07041229 | Comparison of Methods for Removing Large Benign Broad-based Epithelial Neoplasms of the Colon: ESD and EMR.(ESDEMR) | enrolling by invitation | N/A | 110 | Pirogov Russian National Research Medical UniversityOTHER | 1 | Jun 27, 2025 | clinicaltrials |
| NCT07023848 | PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors | enrolling by invitation | Early Phase 1 | 10 | Affiliated Hospital of Jiangnan UniversityOTHER | 1 | Jun 17, 2025 | clinicaltrials |
| NCT07023861 | The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies | enrolling by invitation | Early Phase 1 | 20 | Affiliated Hospital of Jiangnan UniversityOTHER | 1 | Jun 17, 2025 | clinicaltrials |
| NCT07016737 | Immunochemotherapy ± Salvage Chemoradiation for Local Recurrence of Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy(ESO-Nanjing12) | enrolling by invitation | Phase 3 | 79 | Ye jinjunOTHER | 1 | Jun 12, 2025 | clinicaltrials |
Data updated 22 days agoSource updated Mar 31, 2026source: clinicaltrials